Nicholas Draeger
Plus aucun poste en cours
Profil
Nicholas Draeger served as the Chief Executive Officer & Director at Novaremed AG in 2019.
Prior to that, he worked as an Investment Director at Octa Phillip Bioscience Advisory Pty Ltd., a Research Analyst at Adamant Biomedical Investments AG, and an Analyst at Crédit Agricole Cheuvreux SA in 2001.
He holds an MBA from Warwick Business School, an undergraduate degree from the University of KwaZulu-Natal, and a doctorate from the University of Cambridge.
Anciens postes connus de Nicholas Draeger
| Sociétés | Poste | Fin |
|---|---|---|
Novaremed AG
 Novaremed AG Pharmaceuticals: MajorHealth Technology Novaremed AG operates as a pharmaceutical company. It develops NEB74S, a molecule for the treatment of chronic pain. The company was founded by Eliahu Kaplan in 2008 and is headquartered in Petah Tikva, Israel. | Directeur Général | 29/07/2019 |
Crédit Agricole Cheuvreux SA
 Crédit Agricole Cheuvreux SA Investment Banks/BrokersFinance In May 2013, Kepler Capital Markets SA completed the acquisition of Crédit Agricole Cheuvreux SA from Crédit Agricole Corporate & Investment Bank SA, a unit of Crédit Agricole SA. Kepler Capital Markets intends to combine its business with Crédit Agricole Cheuvreux under a new entity, Kepler Cheuvreux, in 2013, and will be headquartered in Paris. They will have offices in Amsterdam, Boston, Frankfurt, Geneva, London, Madrid, Milan, New York, San Francisco, Stockholm, Vienna and Zurich. | Analyst-Equity | 18/12/2001 |
Octa Phillip Bioscience Advisory Pty Ltd.
 Octa Phillip Bioscience Advisory Pty Ltd. Investment ManagersFinance Octa Phillip Bioscience Advisory Pty Ltd (Octa Phillip Bioscience) is a private equity firm founded in 2003. The firm is headquartered in Sydney, Australia. | Director of Investments | - |
Adamant Biomedical Investments AG
 Adamant Biomedical Investments AG Investment ManagersFinance Adamant Biomedical Investments AG (Adamant) is the subsidiary of Bellevue Group AG (SW: BBN) in Switzerland. The firm was established in 2000 as a joint venture between Swiss Life Asset Management and three partners, formerly with the Bellevue Group (which comprises BB Biotech and BB Medtech). The firm's name derives from the Greek word for 'uncut diamond' and refers to their philosophy of uncovering hidden value. Located in Zurich, Adamant is a biomedical sector specialist. The firm manages sector-specific portfolios domiciled in Luxembourg. Their clients are institutions. | Analyst-Equity | - |
Formation de Nicholas Draeger
| University of Cambridge | Doctorate Degree |
| Warwick Business School | Masters Business Admin |
| University of KwaZulu-Natal | Undergraduate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Adamant Biomedical Investments AG
Adamant Biomedical Investments AG Investment ManagersFinance Adamant Biomedical Investments AG (Adamant) is the subsidiary of Bellevue Group AG (SW: BBN) in Switzerland. The firm was established in 2000 as a joint venture between Swiss Life Asset Management and three partners, formerly with the Bellevue Group (which comprises BB Biotech and BB Medtech). The firm's name derives from the Greek word for 'uncut diamond' and refers to their philosophy of uncovering hidden value. Located in Zurich, Adamant is a biomedical sector specialist. The firm manages sector-specific portfolios domiciled in Luxembourg. Their clients are institutions. | Finance |
Crédit Agricole Cheuvreux SA
Crédit Agricole Cheuvreux SA Investment Banks/BrokersFinance In May 2013, Kepler Capital Markets SA completed the acquisition of Crédit Agricole Cheuvreux SA from Crédit Agricole Corporate & Investment Bank SA, a unit of Crédit Agricole SA. Kepler Capital Markets intends to combine its business with Crédit Agricole Cheuvreux under a new entity, Kepler Cheuvreux, in 2013, and will be headquartered in Paris. They will have offices in Amsterdam, Boston, Frankfurt, Geneva, London, Madrid, Milan, New York, San Francisco, Stockholm, Vienna and Zurich. | Finance |
Octa Phillip Bioscience Advisory Pty Ltd.
Octa Phillip Bioscience Advisory Pty Ltd. Investment ManagersFinance Octa Phillip Bioscience Advisory Pty Ltd (Octa Phillip Bioscience) is a private equity firm founded in 2003. The firm is headquartered in Sydney, Australia. | Finance |
Novaremed AG
Novaremed AG Pharmaceuticals: MajorHealth Technology Novaremed AG operates as a pharmaceutical company. It develops NEB74S, a molecule for the treatment of chronic pain. The company was founded by Eliahu Kaplan in 2008 and is headquartered in Petah Tikva, Israel. | Health Technology |
